We are currently conducting a larger study with age and BMI matched Non-DM participants and T2DM participants that do not take diabetes medications that use an insulin infusion protocol of 600 pmol/L and involves an analysis of the genome of SLC30A8. This evidence concerns the gene SLC30A8 and type 2 diabetes mellitus.